Mark Jacobson, M.A
2020
In 2020, Mark Jacobson, M.A earned a total compensation of $2.4M as Chief Operating Officer at Axsome Therapeutics, a 21% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $195,000 |
|---|---|
| Option Awards | $1,333,376 |
| Salary | $375,000 |
| Stock Awards | $461,629 |
| Total | $2,365,005 |
MA received $1.3M in option awards, accounting for 56% of the total pay in 2020.
MA also received $195K in non-equity incentive plan, $375K in salary and $461.6K in stock awards.
Rankings
In 2020, Mark Jacobson, M.A's compensation ranked 4,795th out of 13,090 executives tracked by ExecPay. In other words, MA earned more than 63.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,795 out of 13,090 | 63rd |
Division Manufacturing | 1,951 out of 5,621 | 65th |
Major group Chemicals And Allied Products | 766 out of 2,254 | 66th |
Industry group Drugs | 659 out of 1,954 | 66th |
Industry Pharmaceutical Preparations | 498 out of 1,459 | 66th |
Pay ratio
| Mark Jacobson, M.A's Pay | $2,365,005 |
|---|---|
| Median Employee's Pay | $299,771 |
| Pay Ratio | 8to 1 |
In 2020, the annual total compensation of Mark Jacobson, M.A was $2,365,005.
The annual total compensation of the median employee at Axsome Therapeutics was $299,771.
The ratio of Mark Jacobson, M.A's pay to the pay of median employee was therefore 8 to one.
Source: SEC filing on April 23, 2021.
MA's colleagues
We found three more compensation records of executives who worked with Mark Jacobson, M.A at Axsome Therapeutics in 2020.